Hypoxia-induced and A2A adenosine receptorindependent T-cell suppression is short lived and easily reversible

International Immunology

Volumn 26, Issue 2, 2014, Pages 83-91

  Ohta, Akio ^a   Madasu, Manasa ^a   Subramanian, Meenakshi ^a   Kini, Radhika ^a   Jones, Graham ^a   Choukèr, Alexander ^b   Ohta, Akiko ^a   Sitkovsky, Michail ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

IFN ; Immunosuppression; Inflammation; Oxygen; Tumor microenvironment

Indexed keywords

IFN-Γ; IMMUNOSUPPRESSION; INFLAMMATION; OXYGEN; TUMOR MICROENVIRONMENT;

ADENOSINE; ANIMALS; ANOXIA; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; IMMUNOSUPPRESSION; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A2A; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUMOR MICROENVIRONMENT;

EID: 84894029679     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt045     Document Type: Article

References (61)

1. Lawrence, T., Willoughby, D. A. and Gilroy, D. W. 2002. Antiinflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2:787.
2. Mellor, A. L. and Munn, D. H. 2008. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat. Rev. Immunol. 8:74.
3. Sitkovsky, M. V., Lukashev, D., Apasov, S. et al. 2004. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22:657.
4. Zarek, P. E., Huang, C. T., Lutz, E. R. et al. 2008. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111:251.
5. Ohta, A., Ohta, A., Madasu, M. et al. 2009. A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J. Immunol. 183:5487.
6. Ohta, A. and Sitkovsky, M. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414:916.
7. Thiel, M., Chouker, A., Ohta, A. et al. 2005. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3:e174.
8. Ohta, A., Gorelik, E., Prasad, S. J. et al. 2006. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl Acad. Sci. USA 103:13132.
9. Synnestvedt, K., Furuta, G. T., Comerford, K. M. et al. 2002. Ecto- 5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110:993.
10. Deaglio, S. and Robson, S. C. 2011. Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv. Pharmacol. 61:301.
11. Decking, U. K., Schlieper, G., Kroll, K. and Schrader, J. 1997. Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ. Res. 81:154.
12. Kobayashi, S., Zimmermann, H. and Millhorn, D. E. 2000. Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J. Neurochem. 74:621.
13. Choukèr, A., Thiel, M., Lukashev, D. et al. 2008. Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway. Mol. Med. 14:116.
14. Takagi, H., King, G. L., Robinson, G. S., Ferrara, N. and Aiello, L. P. 1996. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest. Ophthalmol. Vis. Sci. 37:2165.
15. Kobayashi, S., Conforti, L., Pun, R. Y. and Millhorn, D. E. 1998. Adenosine modulates hypoxia-induced responses in rat PC12 cells via the A2A receptor. J. Physiol. 508(Pt 1):95.
16. Takagi, H., King, G. L. and Aiello, L. P. 1998. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 47:1480.
17. Fisher, J. W. and Brookins, J. 2001. Adenosine A(2A) and A(2B) receptor activation of erythropoietin production. Am. J. Physiol. Renal Physiol. 281:F826.
18. O'Driscoll, C. M. and Gorman, A. M. 2005. Hypoxia induces neurite outgrowth in PC12 cells that is mediated through adenosine A2A receptors. Neuroscience 131:321.
19. Coney, A. M. and Marshall, J. M. 1998. Role of adenosine and its receptors in the vasodilatation induced in the cerebral cortex of the rat by systemic hypoxia. J. Physiol. 509(Pt 2):507.
20. Koos, B. J. and Maeda, T. 2001. Adenosine A(2A) receptors mediate cardiovascular responses to hypoxia in fetal sheep. Am. J. Physiol. Heart Circ. Physiol. 280:H83.
21. Grenz, A., Zhang, H., Weingart, J. et al. 2007. Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia. Am. J. Physiol. Renal Physiol. 293:F1501.
22. Chen, J. F., Huang, Z., Ma, J. et al. 1999. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19:9192.
23. Ohta, A., Kjaergaard, J., Sharma, S. et al. 2009. In vitro induction of T cells that are resistant to A2 adenosine receptor-mediated immunosuppression. Br. J. Pharmacol. 156:297.
24. Loeffler, D. A., Juneau, P. L. and Masserant, S. 1992. Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation. Br. J. Cancer 66:619.
25. Naldini, A., Carraro, F., Silvestri, S. and Bocci, V. 1997. Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells. J. Cell. Physiol. 173:335.
26. Caldwell C. C., Kojima, H., Lukashev, D. et al. 2001. Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 167:6140.
27. Atkuri, K. R., Herzenberg, L. A. and Herzenberg, L. A. 2005. Culturing at atmospheric oxygen levels impacts lymphocyte function. Proc. Natl Acad. Sci. USA 102:3756.
28. Ohta, A., Diwanji, R., Kini, R., Subramanian, M., Ohta, A. and Sitkovsky, M. 2011. In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment. Front. Immunol. 2:27.
29. Fredholm, B. B., Ijzerman, A. P., Jacobson, K. A., Linden, J. and Müller, C. E. 2011. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol. Rev. 63:1.
30. Hale, L. P., Braun, R. D., Gwinn, W. M., Greer, P. K. and Dewhirst, M. W. 2002. Hypoxia in the thymus: role of oxygen tension in thymocyte survival. Am. J. Physiol. Heart Circ. Physiol. 282:H1467.
31. Braun, R. D., Lanzen, J. L., Snyder, S. A. and Dewhirst, M. W. 2001. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am. J. Physiol. Heart Circ. Physiol. 280:H2533.
32. Karhausen, J., Haase, V. H. and Colgan, S. P. 2005. Inflammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle 4:256.
33. Krieger, J. A., Landsiedel, J. C. and Lawrence, D. A. 1996. Differential in vitro effects of physiological and atmospheric oxygen tension on normal human peripheral blood mononuclear cell proliferation, cytokine and immunoglobulin production. Int. J. Immunopharmacol. 18:545.
34. Carswell, K. S., Weiss, J. W. and Papoutsakis, E. T. 2000. Low oxygen tension enhances the stimulation and proliferation of human T lymphocytes in the presence of IL-2. Cytotherapy 2:25.
35. Roman, J., Rangasamy, T., Guo, J. et al. 2010. T-cell activation under hypoxic conditions enhances IFN-gamma secretion. Am. J. Respir. Cell Mol. Biol. 42:123.
36. Bynum, J. W. 1980. Characterization of adenosine-induced cytostasis in melanoma cells. Cancer Res. 40:2147.
37. Koshiba, M., Kojima, H., Huang, S., Apasov, S. and Sitkovsky, M. V. 1997. Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J. Biol. Chem. 272:25881.
38. Gajewski, T. F., Meng, Y., Blank, C. et al. 2006. Immune resistance orchestrated by the tumor microenvironment. Immunol. Rev. 213:131.
39. Rabinovich, G. A., Gabrilovich, D. and Sotomayor, E. M. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25:267.
40. Harris, A. L. 2002. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2:38.
41. Brown, J. M. and Wilson, W. R. 2004. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer 4:437.
42. Blay, J., White, T. D. and Hoskin, D. W. 1997. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 57:2602.
43. Semenza, G. L. 2007. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem. J. 405:1.
44. Majmundar, A. J., Wong, W. J. and Simon, M. C. 2010. Hypoxiainducible factors and the response to hypoxic stress. Mol. Cell 40:294.
45. Kominsky, D. J., Campbell, E. L. and Colgan, S. P. 2010. Metabolic shifts in immunity and inflammation. J. Immunol. 184:4062.
46. Lukashev, D., Klebanov, B., Kojima, H. et al. 2006. Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J. Immunol. 177:4962.
47. Guo, J., Lu, W., Shimoda, L. A., Semenza, G. L. and Georas, S. N. 2009. Enhanced interferon-gamma gene expression in T cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1-alpha-deficient mice. Int. Arch. Allergy Immunol. 149:98.
48. Neumann, A. K., Yang, J., Biju, M. P. et al. 2005. Hypoxia inducible factor 1 alpha regulates T cell receptor signal transduction. Proc. Natl Acad. Sci. USA 102:17071.
49. Belenky, P., Bogan, K. L. and Brenner, C. 2007. NAD+ metabolism in health and disease. Trends Biochem. Sci. 32:12.
50. Adriouch, S., Hubert, S., Pechberty, S., Koch-Nolte, F., Haag, F. and Seman, M. 2007. NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J. Immunol. 179:186.
51. Wang, J., Nemoto, E., Kots, A. Y., Kaslow, H. R. and Dennert, G. 1994. Regulation of cytotoxic T cells by ecto-nicotinamide adenine dinucleotide (NAD) correlates with cell surface GPIanchored/ arginine ADP-ribosyltransferase. J. Immunol. 153:4048.
52. Okamoto, S., Azhipa, O., Yu, Y., Russo, E. and Dennert, G. 1998. Expression of ADP-ribosyltransferase on normal T lymphocytes and effects of nicotinamide adenine dinucleotide on their function. J. Immunol. 160:4190.
53. Ohlrogge, W., Haag, F., Löhler, J. et al. 2002. Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2- deficient mice. Mol. Cell. Biol. 22:7535.
54. Seman, M., Adriouch, S., Scheuplein, F. et al. 2003. NADinduced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19:571.
55. Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C. and Schumacker, P. T. 1998. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 95:11715.
56. Chandel, N. S., McClintock, D. S., Feliciano, C. E. et al. 2000. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J. Biol. Chem. 275:25130.
57. Chang, S. W., Stelzner, T. J., Weil, J. V. and Voelkel, N. F. 1989. Hypoxia increases plasma glutathione disulfide in rats. Lung 167:269-276.
58. Mansfield, K. D., Simon, M. C. and Keith, B. 2004. Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J. Appl. Physiol. 97:1358.
59. Cemerski, S., Cantagrel, A., Van Meerwijk, J. P. and Romagnoli, P. 2002. Reactive oxygen species differentially affect T cell receptorsignaling pathways. J. Biol. Chem. 277:19585.
60. Klemke, M., Wabnitz, G. H., Funke, F., Funk, B., Kirchgessner, H. and Samstag, Y. 2008. Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity 29:404.
61. Larbi, A., Cabreiro, F., Zelba, H. et al. 2010. Reduced oxygen tension results in reduced human T cell proliferation and increased intracellular oxidative damage and susceptibility to apoptosis upon activation. Free Radic. Biol. Med. 48:26.